Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases.
Leone JP, Emblem KE, Weitz M, Gelman RS, Schneider BP, Freedman RA, Younger J, Pinho MC, Sorensen AG, Gerstner ER, Harris G, Krop IE, Morganstern D, Sohl J, Hu J, Kasparian E, Winer EP, Lin NU. Leone JP, et al. Among authors: sorensen ag. Breast Cancer Res. 2020 Nov 30;22(1):131. doi: 10.1186/s13058-020-01372-w. Breast Cancer Res. 2020. PMID: 33256829 Free PMC article. Clinical Trial.
Anti-vascular endothelial growth factor therapy for malignant glioma.
Gerstner ER, Sorensen AG, Jain RK, Batchelor TT. Gerstner ER, et al. Among authors: sorensen ag. Curr Neurol Neurosci Rep. 2009 May;9(3):254-62. doi: 10.1007/s11910-009-0037-2. Curr Neurol Neurosci Rep. 2009. PMID: 19348715 Free PMC article. Review.
A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients.
Sorensen AG, Batchelor TT, Zhang WT, Chen PJ, Yeo P, Wang M, Jennings D, Wen PY, Lahdenranta J, Ancukiewicz M, di Tomaso E, Duda DG, Jain RK. Sorensen AG, et al. Cancer Res. 2009 Jul 1;69(13):5296-300. doi: 10.1158/0008-5472.CAN-09-0814. Epub 2009 Jun 23. Cancer Res. 2009. PMID: 19549889 Free PMC article.
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.
Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, Halpin C, Padera TP, Tyrrell A, Sorensen AG, Jain RK, di Tomaso E. Plotkin SR, et al. Among authors: sorensen ag. N Engl J Med. 2009 Jul 23;361(4):358-67. doi: 10.1056/NEJMoa0902579. Epub 2009 Jul 8. N Engl J Med. 2009. PMID: 19587327 Free PMC article.
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
Batchelor TT, Duda DG, di Tomaso E, Ancukiewicz M, Plotkin SR, Gerstner E, Eichler AF, Drappatz J, Hochberg FH, Benner T, Louis DN, Cohen KS, Chea H, Exarhopoulos A, Loeffler JS, Moses MA, Ivy P, Sorensen AG, Wen PY, Jain RK. Batchelor TT, et al. Among authors: sorensen ag. J Clin Oncol. 2010 Jun 10;28(17):2817-23. doi: 10.1200/JCO.2009.26.3988. Epub 2010 May 10. J Clin Oncol. 2010. PMID: 20458050 Free PMC article. Clinical Trial.
Diffusion and diffusion tensor imaging in brain cancer.
Gerstner ER, Sorensen AG. Gerstner ER, et al. Among authors: sorensen ag. Semin Radiat Oncol. 2011 Apr;21(2):141-6. doi: 10.1016/j.semradonc.2010.10.005. Semin Radiat Oncol. 2011. PMID: 21356481 Review.
T(1)- and T(2)(*)-dominant extravasation correction in DSC-MRI: part II-predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients.
Emblem KE, Bjornerud A, Mouridsen K, Borra RJ, Batchelor TT, Jain RK, Sorensen AG. Emblem KE, et al. Among authors: sorensen ag. J Cereb Blood Flow Metab. 2011 Oct;31(10):2054-64. doi: 10.1038/jcbfm.2011.39. Epub 2011 Apr 20. J Cereb Blood Flow Metab. 2011. PMID: 21505476 Free PMC article. Clinical Trial.
233 results